Ftse Mib
37.677,27
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.541,56
-1,30%
NASDAQ
17.349,89
-0,68%
Bitcoin
81.288,76
3,59%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rani Therapeutics Holdings Inc (RANI) Rani Therapeutics Holdings Inc (RANI) Notizie

Rani Therapeutics Holdings Inc

RANI
1,435
-0,045 (-3,04%)
Ultimo aggiornamento: 17:43:04
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202522:05GLOBERani Therapeutics Announces Preclinical Data Demonstrating..
17/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202419:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202414:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202414:10EDGAR2Form 8-K - Current report
14/11/202414:00GLOBERani Therapeutics Reports Third Quarter 2024 Financial..
07/11/202422:05GLOBERani Therapeutics to Participate in Upcoming Investor..
17/10/202414:00GLOBERani Therapeutics Announces New Preclinical Pharmacokinetic..
16/10/202412:06EDGAR2Form 8-K - Current report
16/10/202412:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/10/202414:30GLOBERani Therapeutics Holdings, Inc. Announces Pricing of $10.0..
08/10/202422:05GLOBERani Therapeutics to Participate in the 2024 Maxim..
11/9/202422:10EDGAR2Form 8-K - Current report
03/9/202422:05GLOBERani Therapeutics to Participate in September Investor..
06/8/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:05GLOBERani Therapeutics Reports Second Quarter 2024 Financial..
06/8/202422:04EDGAR2Form 8-K - Current report
29/7/202422:05GLOBERani Therapeutics to Participate in August Investor..
23/7/202412:06EDGAR2Form 8-K - Current report
23/7/202412:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/7/202414:30GLOBERani Therapeutics Holdings, Inc. Announces Pricing of $10.0..
12/7/202423:19EDGAR2Form 8-K - Current report
24/6/202413:00GLOBERani Therapeutics Announces Partnership with ProGen on..
30/5/202422:03EDGAR2Form 8-K - Current report
14/5/202414:00GLOBERani Therapeutics to Participate in May Investor Conferences
09/5/202414:00GLOBERani Therapeutics to Present Clinical and Preclinical Data..
06/5/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:05GLOBERani Therapeutics Reports First Quarter 2024 Financial..
06/5/202422:04EDGAR2Form 8-K - Current report
20/3/202421:05GLOBERani Therapeutics Reports Fourth Quarter and Full Year 2023..
15/3/202421:05GLOBERani Therapeutics to Report Fourth Quarter and Full Year..
Apertura: 1,48 Min: 1,41 Max: 1,49
Chiusura: 1,48

La tua Cronologia

NASDAQ
RANI
Rani Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci